Business News
Bioactivx Raises $3 Mn as Synthetic Wound-Care Product Awaits Singapore Approval
Singapore's Cocoon Capital and Martin Krupp co-led the pre-Series A round, which will fund manufacturing and regulatory expansion as Bioactiv Matrix awaits approval in its home market.